ARAY · Accuray Incorporated
AI read · Bad for ARAY
The AI's read
Accuray posted Q4 revenue of $100.9M, down 21% year-over-year, and full-year revenue fell 12%. Product revenue weakness, especially in China, forced a TCW deal that converts $40M of debt into preferred equity plus a $15M cash injection. The market dropped the stock about 5.8% after the print and RSI near 35 shows some oversold pressure. That said the company is tiny (market cap ~$35M) and thin liquidity means downside can still accelerate on execution misses. We lean bearish: a sharp top-line hit plus balance-sheet dilution raises near-term downside and execution risk. Conviction 84% because the catalyst is fresh, company-specific, and the market reaction confirms concern.